Jordi Remón - Publications, H-index & Citations

Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France 法国晚期和转移性肺癌的治疗模式与结果：来自法国流行病学策略与医学经济学（ESME）数据库的研究结果

IF8.3

2026-08-07

OAAI

E. Gobbini; M.H. Diallo; C. Clément-Duchene; C. Chouaid; S. Hiret; C. Audigier-Valette; A. Bizieux; D. Debieuvre; X. Quantin; Y. Le Guen; A. Lemoine; L. Falchero; J. Remon-Masip; L. Bosquet; M. Pérol; N. Girard

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation 抗体药物偶联物在特定实体瘤中的应用：基于ETOP IBCSG Partners基金会第三次研讨会成果的立场声明更新

IF4.4

2026-08-01

PREAI

Girard, Nicolas; Carton, Matthieu; Macouillard, Pauline; Debieuvre, Didier; Quantin, Xavier; Audigier-Valette, Clarisse; Lena, Herve; Filleron, Thomas; Gervais, Radj; Schott, Roland; Remon, Jordi; Justeau, Gregoire; Bosquet, Lise; Martin, Anne-Laure; Chouaid, Christos; Perol, Maurice

Efficacy of Alectinib for ALK-positive NSCLC According to Tumor Burden and Body Mass Index: a Pooled Analysis of the Randomized Phase III Trials ALEX and J-ALEX 根据肿瘤负荷和体重指数评估阿来替尼对ALK阳性NSCLC的疗效：ALEX和J-ALEX随机III期试验的合并分析

IF8.3

2026-07-01

PREAI

Peters, S.; Meyer, M. -l.; Andre, F.; Argiles, G.; Azizi, A. A.; Banerjee, S.; Burgers, S.; Curigliano, G.; Drago, J. Z.; Fontana, E.; Garon, E. B.; Klumper, N.; Le Bescond, L.; Lopez-Rios, F.; Mountzios, G.; Passaro, A.; Paz-Ares, L.; Pistilli, B.; Powles, T.; Reguart, N.; Remon, J.; Schmelzle, T.; Skynner, M. J.; Smit, E.; Smyth, E.; Swanton, C.; Van Cutsem, E.; Loi, S.; Stahel, R. A.

European Journal of Cancer

IF7.1

2026-06-05

OAAI

Marco Tagliamento; Marco Bruzzone; Eva Blondeaux; Filippo Dall’Olio; Mihaela Aldea; Carlo Genova; Arianna Marinello; Jordi Remon; Lizza E.L. Hendriks; Lucia Del Mastro; David Planchard; Fabrice Barlesi; Matteo Lambertini; Benjamin Besse

Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)性别在非小细胞肺癌（NSCLC）中对处于研发阶段的抗体药物偶联物（ADCs）耐受性的差异

KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians KRAS G12C突变非小细胞肺癌：临床医师实用指南

IF8.3

2026-06-01

PREAI

Parisi, C.; Banini, M.; Mantuano, F.; Aldea, M.; Abdayem, P.; Derosa, L.; Frelaut, M.; Lavaud, P.; Robert, A.; Simon, S.; Gazzah, A.; Hollebecque, A.; Massard, C.; Besse, B.; Remon, J.; Wagner, A.; Pistilli, B.; Vaz-Luis, I.; Planchard, D.; Barlesi, F.

Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial 作者更正：Alectinib与bevacizumab联合作为ALK重排非小细胞肺癌的一线治疗（ALEK-B）：一项单臂、二期临床试验

IF10.5

2026-05-06

PREAI

Jordi Remon; Giulia La-Cava; Maxime Borgeaud; Stephanie P.L. Saw; Lizza EL Hendriks; Biagio Ricciuti

Nature Communications

IF15.7

2025-12-12

OAAI

Oscar Arrieta; Luis Lara-Mejía; Eduardo Rios-Garcia; Enrique Caballé-Perez; Luis Cabrera-Miranda; Maritza Ramos-Ramírez; David Dávila-Dupont; Andrés F. Cardona; Graciela Cruz-Rico; Jordi Remon; Alexandra Garcilazo-Reyes; Rafael Rosell

Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies 血管生成与胸腺上皮肿瘤：从临床前见解到不同的治疗途径及联合策略

Corrigendum to ‘Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer’ [Journal of Thoracic Oncology, Volume 19 Issue 1 (2024) 119-129]勘误：‘Concurrent genomic alterations对ALK重排非小细胞肺癌患者临床结局的影响’ [胸外科肿瘤学杂志，第19卷第1期（2024年）119-129页]

IF10.5

2025-11-13

PREAI

D. Miliziano; C. Sciortino; S. Manglaviti; M. Ganzinelli; A. Lopez-Gutierrez; M. Occhipinti; C. Proto; F. De Braud; B. Besse; G. Lo Russo; J. Remon

Journal of Thoracic Oncology

IF20.8

2025-10-27

PREAI

Luis Lara-Mejía; Andres F. Cardona; Luis Mas; Claudio Martin; Suraj Samtani; Luis Corrales; Graciela Cruz-Rico; Jordi Remon; Marco Galvez-Nino; Rossana Ruiz; Eduardo Rios-Garcia; Fernanda Tejada; Natalia Lozano-Vazquez; Rafael Rosell; Oscar Arrieta

Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study EGFR突变晚期非小细胞肺癌患者在接受一线奥希替尼治疗后，接受卡铂联合培美曲塞二线治疗的实际疗效：一项国际多中心队列研究

Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group 纳入临床试验的可切除III期非小细胞肺癌（NSCLC）定义：由EORTC肺癌组领导的泛欧洲多学科专家小组的临床病例回顾

IF4.4

2025-10-16

PREAI

Igor Gomez-Randulfe; Federico Monaca; Ornella Cantale; Maria Lucia Reale; Loredana Mrak; Lodovica Zullo; Sofia Silva Diaz; Marta Zaragoza Bueno; Marya Alejandra Maridueña Moreno; Charlotte Davis; Samantha Cox; Daniel Lee; Riyaz Shah; Tom Geldart; Javier Baena; Jose Carlos Benitez; M.A. Rosario Garcia Campelo; Jordi Remon; David Planchard; Domenico Galetta; Marcello Tiseo; Diego Cortinovis; Giulio Metro; Emilio Bria; Francesco Passiglia; Silvia Novello; Raffaele Califano

Unresectable stage III non-small-cell lung cancer: state of the art and challenges 不可切除的III期非小细胞肺癌：最新进展与挑战

IF4.4

2025-10-14

PREAI

Mariana Brandão; Elena Prisciandaro; Eleni Xenophontos; Alessio Mariolo; Amir H. Sadeghi; Andrea R. Filippi; Antonin Levy; Artur Bandura; Caroline Caramella; Chris Dickhoff; Constance de Margerie-Mellon; Corinne Faivre-Finn; Daniel Portik; David Sanchez-Lorente; Dirk De Ruysscher; Egbert Smit; Elisa Gobbini; Elie Fadel; Enrico Ruffini; Emanuela Olmetto; Francesco Cortiula; Idris Bahce; Ilias Houda; Isabelle Opitz; Jarushka Naidoo; John Edwards; Jordi Remon; José Carlos Benitez; Juan Carlos Trujillo; Jules Derks; Karim Amrane; Koen J. Hartemink; Konstantinos Stathopoulos; Lizza E.L. Hendriks; Manoli Iglesias; Mario Occhipinti; Matthias Guckenberger; Niccolo Giaj Levra; Nicolas Girard; Noemi Reguart; Olaf Mercier; Paolo Bironzo; Paul Hofman; René Horsleben Petersen; Riccardo De Angelis; Ronan Abgral; Safae Terrisse; Sanjay Popat; Thomas Pierret; Torsten Gerriet Blum; Umberto Ricardi; Valeria Dionisi; Thierry Berghmans; Anne-Marie C. Dingemans

Nature Reviews Clinical Oncology

IF82.2

2025-10-09

PREAI

Jordi Remon; Antonin Levy; Romane Gille; Isabelle Martel-Lafay; Martina Bortolot; Lizza E. L. Hendriks; Corinne Faivre-Finn; Natasha Leighl; Martin Reck; Maurice Pérol

Induction immunotherapy plus chemotherapy for Pancoast lung cancer tumors: are we ready to shift our standards?诱导免疫疗法联合化疗治疗Pancoast肺癌肿瘤：我们是否已准备好转变标准？

Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial 仑伐替尼联合帕博利珠单抗治疗经治性转移性B3胸腺瘤和胸腺癌（PECATI）：一项单臂、II期临床试验

IF8.3

2025-09-04

OAAI

J. Remon; F. Porez; H. Clermidy; O. Mercier; D. Mitilian; N. Guezour; C. Caramella; P. Pradère; S. Saing; V.T. de Montpreville; A. Botticella; E. Fadel

lancet oncology

IF0

2025-09-01

PREAI

Jordi Remon; Paolo Bironzo; Nicolas Girard; Laurence Bigay-Game; Oscar Juan-Vidal; Javier de Castro; Noemí Reguart; Laurent Greillier; Sophie Cousin; Eric Dansin; Margarita Majem; Reyes Bernabé; Joaquin Mosquera Martinez; Marta Díaz; Alba Meya; Daniel Alcalá-López; Alicia García-Sanz; Luisella Righi; Silvia Novello; Benjamin Besse

Radioimmunotherapy for lung and head and neck cancers: A comparative review of clinical trial results and sequencing strategies 放射性免疫疗法在肺癌和头颈癌中的应用：临床试验结果与序贯策略的对比综述

Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group 可切除的III期非小细胞肺癌的定义：一项来自EORTC肺癌组的系统评价

IF10.5

2025-08-27

PREAI

Danny Lavigne; Yungan Tao; Cecile Le Péchoux; Angela Botticella; France Nguyen; Roger Sun; Pierre Blanchard; Jordi Remon; Eric Deutsch; Antonin Levy

De-escalation strategies with targeted therapies in non-small cell lung cancer 靶向治疗在非小细胞肺癌中的降级策略

IF4.4

2025-07-19

PREAI

E. Xenophontos; N. Giaj Levra; V. Durieux; W.H. van Geffen; G. Grisay; C. De la Pinta Alonso; H. Arasanz; E. Prisciandaro; R. Ferrara; J. Derks; J. Von der Thusen; C. Dickhoff; M. Brandão; C. Faivre-Finn; J. Edwards; D.De Ruysscher; J. Remon; A-M.C. Dingemans; T. Berghmans